 AIDS transfusion recipient summary HIV virus recipients infectious blood blood products product March Self-elimination at-risk donors several years donor blood number infected donations donors multiply patient immune system due numerous antigens iron red cells plasma immune system variable response added exposure HIV virus incubation period progression variable small number patients at-risk groups many therapeutic intervention Natural history disease continual monitoring ultimate outcome transfusion recipients